

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | nuclear pore complex assembly (GO:0051292) | 4.79567777 |
| 2 | embryonic process involved in female pregnancy (GO:0060136) | 4.29106443 |
| 3 | alpha-linolenic acid metabolic process (GO:0036109) | 4.24131021 |
| 4 | COPII vesicle coating (GO:0048208) | 4.19907704 |
| 5 | urea metabolic process (GO:0019627) | 4.00235153 |
| 6 | urea cycle (GO:0000050) | 4.00235153 |
| 7 | desmosome organization (GO:0002934) | 3.96214742 |
| 8 | nuclear pore organization (GO:0006999) | 3.86513675 |
| 9 | regulation of cholesterol homeostasis (GO:2000188) | 3.83480410 |
| 10 | L-phenylalanine catabolic process (GO:0006559) | 3.83232962 |
| 11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.83232962 |
| 12 | macroautophagy (GO:0016236) | 3.73240998 |
| 13 | lysine metabolic process (GO:0006553) | 3.68238141 |
| 14 | lysine catabolic process (GO:0006554) | 3.68238141 |
| 15 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.63326152 |
| 16 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.62433114 |
| 17 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.60369566 |
| 18 | L-phenylalanine metabolic process (GO:0006558) | 3.60369566 |
| 19 | cysteine metabolic process (GO:0006534) | 3.53556847 |
| 20 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.53323821 |
| 21 | nitrogen cycle metabolic process (GO:0071941) | 3.52968551 |
| 22 | regulation of RNA export from nucleus (GO:0046831) | 3.52289763 |
| 23 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.50987987 |
| 24 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.48585545 |
| 25 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.43686769 |
| 26 | fatty acid transmembrane transport (GO:1902001) | 3.39451751 |
| 27 | pore complex assembly (GO:0046931) | 3.38473360 |
| 28 | carnitine shuttle (GO:0006853) | 3.34634970 |
| 29 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.32813362 |
| 30 | phospholipid homeostasis (GO:0055091) | 3.32013166 |
| 31 | protein-lipid complex assembly (GO:0065005) | 3.27368190 |
| 32 | protein carboxylation (GO:0018214) | 3.23227225 |
| 33 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.23227225 |
| 34 | low-density lipoprotein particle clearance (GO:0034383) | 3.22220234 |
| 35 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.21485951 |
| 36 | 2-oxoglutarate metabolic process (GO:0006103) | 3.20898297 |
| 37 | positive regulation of lipid catabolic process (GO:0050996) | 3.20370995 |
| 38 | negative regulation of fatty acid transport (GO:2000192) | 3.17646459 |
| 39 | vesicle coating (GO:0006901) | 3.17272509 |
| 40 | plasma lipoprotein particle assembly (GO:0034377) | 3.16462815 |
| 41 | sulfur amino acid catabolic process (GO:0000098) | 3.16217535 |
| 42 | negative regulation of fibrinolysis (GO:0051918) | 3.14095192 |
| 43 | cell adhesion mediated by integrin (GO:0033627) | 3.11344354 |
| 44 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.08516103 |
| 45 | glutamate metabolic process (GO:0006536) | 3.07301816 |
| 46 | valine metabolic process (GO:0006573) | 3.07049338 |
| 47 | aromatic amino acid family catabolic process (GO:0009074) | 3.05632477 |
| 48 | acetyl-CoA metabolic process (GO:0006084) | 3.03750286 |
| 49 | hypotonic response (GO:0006971) | 3.02166017 |
| 50 | ethanol oxidation (GO:0006069) | 3.01936835 |
| 51 | positive regulation of histone deacetylation (GO:0031065) | 3.01829692 |
| 52 | regulation of histone H3-K27 methylation (GO:0061085) | 3.01151071 |
| 53 | regulation of triglyceride catabolic process (GO:0010896) | 2.97436946 |
| 54 | plasma lipoprotein particle clearance (GO:0034381) | 2.97415851 |
| 55 | cell-substrate junction assembly (GO:0007044) | 2.96276649 |
| 56 | kynurenine metabolic process (GO:0070189) | 2.96250662 |
| 57 | iron ion import (GO:0097286) | 2.94878106 |
| 58 | positive regulation of fatty acid oxidation (GO:0046321) | 2.93509885 |
| 59 | protein localization to endosome (GO:0036010) | 2.93337958 |
| 60 | cell-substrate adherens junction assembly (GO:0007045) | 2.91973269 |
| 61 | focal adhesion assembly (GO:0048041) | 2.91973269 |
| 62 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.91824164 |
| 63 | high-density lipoprotein particle remodeling (GO:0034375) | 2.90328719 |
| 64 | phospholipid efflux (GO:0033700) | 2.90210386 |
| 65 | complement activation, alternative pathway (GO:0006957) | 2.90194898 |
| 66 | pinocytosis (GO:0006907) | 2.89188056 |
| 67 | cholesterol efflux (GO:0033344) | 2.87281761 |
| 68 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.86996718 |
| 69 | homocysteine metabolic process (GO:0050667) | 2.86854768 |
| 70 | fatty acid homeostasis (GO:0055089) | 2.86521071 |
| 71 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.86095245 |
| 72 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.86061256 |
| 73 | regulation of protein activation cascade (GO:2000257) | 2.85102170 |
| 74 | skin morphogenesis (GO:0043589) | 2.84858390 |
| 75 | sodium ion export (GO:0071436) | 2.84224613 |
| 76 | bile acid biosynthetic process (GO:0006699) | 2.82810912 |
| 77 | amino-acid betaine metabolic process (GO:0006577) | 2.82191078 |
| 78 | negative regulation of sterol transport (GO:0032372) | 2.82176386 |
| 79 | negative regulation of cholesterol transport (GO:0032375) | 2.82176386 |
| 80 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.80197229 |
| 81 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.79004860 |
| 82 | short-chain fatty acid metabolic process (GO:0046459) | 2.77314631 |
| 83 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.77066833 |
| 84 | negative regulation of organelle assembly (GO:1902116) | 2.76345307 |
| 85 | response to methylmercury (GO:0051597) | 2.76116525 |
| 86 | adherens junction assembly (GO:0034333) | 2.76085610 |
| 87 | glyoxylate metabolic process (GO:0046487) | 2.74898724 |
| 88 | negative regulation of lipid transport (GO:0032369) | 2.74272817 |
| 89 | fatty acid beta-oxidation (GO:0006635) | 2.74095189 |
| 90 | aspartate family amino acid catabolic process (GO:0009068) | 2.73797462 |
| 91 | cellular response to ethanol (GO:0071361) | 2.73371208 |
| 92 | regulation of fatty acid oxidation (GO:0046320) | 2.72113094 |
| 93 | intracellular lipid transport (GO:0032365) | 2.71096811 |
| 94 | tricarboxylic acid metabolic process (GO:0072350) | 2.70842273 |
| 95 | regulation of apoptotic cell clearance (GO:2000425) | 2.70505682 |
| 96 | regulation of cholesterol storage (GO:0010885) | 2.70086301 |
| 97 | reverse cholesterol transport (GO:0043691) | 2.69999317 |
| 98 | negative regulation of DNA repair (GO:0045738) | 2.69598556 |
| 99 | regulation of complement activation (GO:0030449) | 2.69251842 |
| 100 | fatty acid oxidation (GO:0019395) | 2.69174798 |
| 101 | carnitine transmembrane transport (GO:1902603) | 2.69028396 |
| 102 | intestinal cholesterol absorption (GO:0030299) | 2.67349778 |
| 103 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.67072876 |
| 104 | positive regulation of nuclease activity (GO:0032075) | 2.66299627 |
| 105 | epithelial cell-cell adhesion (GO:0090136) | 2.64931075 |
| 106 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.64488556 |
| 107 | regulation of fibrinolysis (GO:0051917) | 2.64436081 |
| 108 | cellular modified amino acid catabolic process (GO:0042219) | 2.64356131 |
| 109 | receptor catabolic process (GO:0032801) | 2.64238460 |
| 110 | hemidesmosome assembly (GO:0031581) | 2.63879366 |
| 111 | serine family amino acid catabolic process (GO:0009071) | 2.63615364 |
| 112 | amino-acid betaine transport (GO:0015838) | 2.63516833 |
| 113 | carnitine transport (GO:0015879) | 2.63516833 |
| 114 | lipid oxidation (GO:0034440) | 2.63362520 |
| 115 | acylglycerol homeostasis (GO:0055090) | 2.61944457 |
| 116 | triglyceride homeostasis (GO:0070328) | 2.61944457 |
| 117 | bile acid metabolic process (GO:0008206) | 2.61829448 |
| 118 | histone H3-K36 demethylation (GO:0070544) | 2.61569213 |
| 119 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.61334036 |
| 120 | regulation of early endosome to late endosome transport (GO:2000641) | 2.60684057 |
| 121 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.60367588 |
| 122 | Golgi organization (GO:0007030) | 2.59690902 |
| 123 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.59370450 |
| 124 | import into cell (GO:0098657) | 2.57540250 |
| 125 | activation of Rac GTPase activity (GO:0032863) | 2.57135262 |
| 126 | mitotic sister chromatid cohesion (GO:0007064) | 2.56248156 |
| 127 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.55332025 |
| 128 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.55280797 |
| 129 | fatty acid catabolic process (GO:0009062) | 2.53817873 |
| 130 | Golgi transport vesicle coating (GO:0048200) | 2.53562205 |
| 131 | COPI coating of Golgi vesicle (GO:0048205) | 2.53562205 |
| 132 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.53294635 |
| 133 | regulation of lipid catabolic process (GO:0050994) | 2.53187120 |
| 134 | sterol homeostasis (GO:0055092) | 2.52911735 |
| 135 | protein-lipid complex subunit organization (GO:0071825) | 2.52056809 |
| 136 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.50828637 |
| 137 | cholesterol homeostasis (GO:0042632) | 2.50402176 |
| 138 | 4-hydroxyproline metabolic process (GO:0019471) | 2.50231866 |
| 139 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.50113177 |
| 140 | positive regulation of extracellular matrix organization (GO:1903055) | 2.49946058 |
| 141 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.47955140 |
| 142 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.46882258 |
| 143 | ER-nucleus signaling pathway (GO:0006984) | 2.46879650 |
| 144 | protein targeting to Golgi (GO:0000042) | 2.46726319 |
| 145 | regulation of protein polyubiquitination (GO:1902914) | 2.45773496 |
| 146 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.45286115 |
| 147 | positive regulation of hormone metabolic process (GO:0032352) | 2.44929818 |
| 148 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.44645713 |
| 149 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.43462948 |
| 150 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.41200513 |
| 151 | negative regulation of anoikis (GO:2000811) | 2.38780204 |
| 152 | mammary gland epithelial cell proliferation (GO:0033598) | 2.37840253 |
| 153 | lipid translocation (GO:0034204) | 2.37749726 |
| 154 | phospholipid translocation (GO:0045332) | 2.37749726 |
| 155 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.35650293 |
| 156 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.35342004 |
| 157 | peptidyl-threonine modification (GO:0018210) | 2.35020372 |
| 158 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.34442356 |
| 159 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.33234300 |
| 160 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.33079203 |
| 161 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.31502517 |
| 162 | response to epidermal growth factor (GO:0070849) | 2.31009985 |
| 163 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.30122290 |
| 164 | intestinal absorption (GO:0050892) | 2.28593869 |
| 165 | mannose metabolic process (GO:0006013) | 2.26576949 |
| 166 | regulation of water loss via skin (GO:0033561) | 2.25784008 |
| 167 | basement membrane organization (GO:0071711) | 2.25767971 |
| 168 | peptidyl-lysine dimethylation (GO:0018027) | 2.25657032 |
| 169 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.25535796 |
| 170 | response to laminar fluid shear stress (GO:0034616) | 2.25190155 |
| 171 | embryonic eye morphogenesis (GO:0048048) | 2.24097664 |
| 172 | histone H3-K9 demethylation (GO:0033169) | 2.23525958 |
| 173 | negative regulation of protein activation cascade (GO:2000258) | 2.23404922 |
| 174 | peptidyl-threonine phosphorylation (GO:0018107) | 2.23249139 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.61162545 |
| 2 | GATA1_22025678_ChIP-Seq_K562_Human | 4.76016198 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.32992504 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.92436873 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.76716766 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.64128068 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.18941804 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.80323250 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.69068252 |
| 10 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.57691869 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.47758446 |
| 12 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.44047364 |
| 13 | GATA1_19941826_ChIP-Seq_K562_Human | 2.43849992 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.38468529 |
| 15 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.20266949 |
| 16 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.17665902 |
| 17 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.99952980 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.96523897 |
| 19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.94646214 |
| 20 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.90865007 |
| 21 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.82514270 |
| 22 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.82514270 |
| 23 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.79956584 |
| 24 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.74757343 |
| 25 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.74625140 |
| 26 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.74398285 |
| 27 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.73563682 |
| 28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.71280965 |
| 29 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.61723193 |
| 30 | GATA2_19941826_ChIP-Seq_K562_Human | 1.60259793 |
| 31 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.59477634 |
| 32 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.56653204 |
| 33 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.50082481 |
| 34 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.49879998 |
| 35 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.49836813 |
| 36 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.48480980 |
| 37 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.47137032 |
| 38 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.45219879 |
| 39 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.43883535 |
| 40 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.43423712 |
| 41 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.43287466 |
| 42 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.43072634 |
| 43 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.42855663 |
| 44 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.42762936 |
| 45 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.42431591 |
| 46 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.41196508 |
| 47 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.39616231 |
| 48 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.38310836 |
| 49 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.36700656 |
| 50 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.35236359 |
| 51 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34764744 |
| 52 | KDM2B_26808549_Chip-Seq_K562_Human | 1.34507289 |
| 53 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.32683950 |
| 54 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.27062342 |
| 55 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.25946672 |
| 56 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.24852900 |
| 57 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.24852900 |
| 58 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.23965720 |
| 59 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.23335558 |
| 60 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.22907584 |
| 61 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.22691864 |
| 62 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.22647784 |
| 63 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20947240 |
| 64 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.20413017 |
| 65 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.19702152 |
| 66 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.18947982 |
| 67 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.18844054 |
| 68 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.18526710 |
| 69 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.18056471 |
| 70 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.17423666 |
| 71 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.17363493 |
| 72 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.16406114 |
| 73 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.16366447 |
| 74 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.16132257 |
| 75 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.13344241 |
| 76 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.13164772 |
| 77 | ATF3_27146783_Chip-Seq_COLON_Human | 1.12696723 |
| 78 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.12407056 |
| 79 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.12307738 |
| 80 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.11759611 |
| 81 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.11510215 |
| 82 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.11455843 |
| 83 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.10797380 |
| 84 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.10307837 |
| 85 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.09913903 |
| 86 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.09728820 |
| 87 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.09437119 |
| 88 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.09081598 |
| 89 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.08768084 |
| 90 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.08614985 |
| 91 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.07491989 |
| 92 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.07318634 |
| 93 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.07030859 |
| 94 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.06901869 |
| 95 | MYC_22102868_ChIP-Seq_BL_Human | 1.06353777 |
| 96 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06260813 |
| 97 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06248812 |
| 98 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.06074493 |
| 99 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.05926987 |
| 100 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05912599 |
| 101 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.05364557 |
| 102 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.04498833 |
| 103 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.04210769 |
| 104 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.04123613 |
| 105 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.03736102 |
| 106 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.02791241 |
| 107 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.02110519 |
| 108 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.01903530 |
| 109 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.01343937 |
| 110 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.01293336 |
| 111 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.00610984 |
| 112 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.00362264 |
| 113 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.00332017 |
| 114 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.00225126 |
| 115 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.99698899 |
| 116 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.98874672 |
| 117 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.97898359 |
| 118 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.96336777 |
| 119 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96191243 |
| 120 | SPI1_23127762_ChIP-Seq_K562_Human | 0.95346084 |
| 121 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95209860 |
| 122 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.95125720 |
| 123 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.94094585 |
| 124 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93939318 |
| 125 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92771060 |
| 126 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.91993215 |
| 127 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87726405 |
| 128 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.85984829 |
| 129 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.85913758 |
| 130 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.85278105 |
| 131 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.84357751 |
| 132 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.84214742 |
| 133 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.83360845 |
| 134 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.83008257 |
| 135 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.82953306 |
| 136 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.81861234 |
| 137 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.80602788 |
| 138 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.78542221 |
| 139 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.78542221 |
| 140 | MAF_26560356_Chip-Seq_TH1_Human | 0.78296851 |
| 141 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.78268618 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.74497664 |
| 2 | MP0005360_urolithiasis | 4.60054311 |
| 3 | MP0005365_abnormal_bile_salt | 3.64476342 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.56266794 |
| 5 | MP0005083_abnormal_biliary_tract | 3.19564360 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 3.09265301 |
| 7 | MP0005451_abnormal_body_composition | 2.94074689 |
| 8 | MP0003252_abnormal_bile_duct | 2.76604822 |
| 9 | MP0010329_abnormal_lipoprotein_level | 2.74607890 |
| 10 | MP0009840_abnormal_foam_cell | 2.66455818 |
| 11 | MP0005409_darkened_coat_color | 2.65791840 |
| 12 | MP0008057_abnormal_DNA_replication | 2.53994188 |
| 13 | MP0003300_gastrointestinal_ulcer | 2.52683453 |
| 14 | MP0003656_abnormal_erythrocyte_physiolo | 2.50705460 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 2.48713172 |
| 16 | MP0004130_abnormal_muscle_cell | 2.36957529 |
| 17 | MP0002009_preneoplasia | 2.28570969 |
| 18 | MP0002877_abnormal_melanocyte_morpholog | 2.22216814 |
| 19 | MP0005408_hypopigmentation | 2.06051466 |
| 20 | MP0003806_abnormal_nucleotide_metabolis | 2.04760324 |
| 21 | MP0004185_abnormal_adipocyte_glucose | 2.03323477 |
| 22 | MP0010234_abnormal_vibrissa_follicle | 2.02132523 |
| 23 | MP0003172_abnormal_lysosome_physiology | 2.01102821 |
| 24 | MP0002118_abnormal_lipid_homeostasis | 1.94099389 |
| 25 | MP0000609_abnormal_liver_physiology | 1.92305155 |
| 26 | MP0005058_abnormal_lysosome_morphology | 1.88949650 |
| 27 | MP0003950_abnormal_plasma_membrane | 1.87159086 |
| 28 | MP0003195_calcinosis | 1.86585004 |
| 29 | MP0002837_dystrophic_cardiac_calcinosis | 1.85799779 |
| 30 | MP0003191_abnormal_cellular_cholesterol | 1.85568194 |
| 31 | MP0001666_abnormal_nutrient_absorption | 1.84530043 |
| 32 | MP0005670_abnormal_white_adipose | 1.79512812 |
| 33 | MP0004233_abnormal_muscle_weight | 1.76150605 |
| 34 | MP0009780_abnormal_chondrocyte_physiolo | 1.75821155 |
| 35 | MP0005666_abnormal_adipose_tissue | 1.72658891 |
| 36 | MP0002166_altered_tumor_susceptibility | 1.70372290 |
| 37 | MP0008961_abnormal_basal_metabolism | 1.63256937 |
| 38 | MP0010678_abnormal_skin_adnexa | 1.61668130 |
| 39 | MP0002796_impaired_skin_barrier | 1.58330056 |
| 40 | MP0005332_abnormal_amino_acid | 1.56258535 |
| 41 | MP0005257_abnormal_intraocular_pressure | 1.54194118 |
| 42 | MP0005375_adipose_tissue_phenotype | 1.47735456 |
| 43 | MP0002396_abnormal_hematopoietic_system | 1.45664720 |
| 44 | MP0002909_abnormal_adrenal_gland | 1.42445536 |
| 45 | MP0004510_myositis | 1.41202406 |
| 46 | MP0003566_abnormal_cell_adhesion | 1.38565429 |
| 47 | MP0004272_abnormal_basement_membrane | 1.34703677 |
| 48 | MP0000569_abnormal_digit_pigmentation | 1.34654770 |
| 49 | MP0000003_abnormal_adipose_tissue | 1.32805306 |
| 50 | MP0000604_amyloidosis | 1.31345297 |
| 51 | MP0002971_abnormal_brown_adipose | 1.31338736 |
| 52 | MP0002254_reproductive_system_inflammat | 1.30856091 |
| 53 | MP0001915_intracranial_hemorrhage | 1.30014490 |
| 54 | MP0002078_abnormal_glucose_homeostasis | 1.29983142 |
| 55 | MP0005319_abnormal_enzyme/_coenzyme | 1.27806147 |
| 56 | MP0003045_fibrosis | 1.27442374 |
| 57 | MP0002060_abnormal_skin_morphology | 1.27341700 |
| 58 | MP0008004_abnormal_stomach_pH | 1.26530797 |
| 59 | MP0003941_abnormal_skin_development | 1.25560429 |
| 60 | MP0005076_abnormal_cell_differentiation | 1.24127619 |
| 61 | MP0004084_abnormal_cardiac_muscle | 1.22768784 |
| 62 | MP0010352_gastrointestinal_tract_polyps | 1.22352714 |
| 63 | MP0003329_amyloid_beta_deposits | 1.18046125 |
| 64 | MP0004264_abnormal_extraembryonic_tissu | 1.17567754 |
| 65 | MP0002086_abnormal_extraembryonic_tissu | 1.15619914 |
| 66 | MP0005621_abnormal_cell_physiology | 1.14644238 |
| 67 | MP0003868_abnormal_feces_composition | 1.13951347 |
| 68 | MP0002269_muscular_atrophy | 1.13278175 |
| 69 | MP0002006_tumorigenesis | 1.11728417 |
| 70 | MP0009643_abnormal_urine_homeostasis | 1.11697548 |
| 71 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.09315218 |
| 72 | MP0000627_abnormal_mammary_gland | 1.09166708 |
| 73 | MP0005334_abnormal_fat_pad | 1.07561078 |
| 74 | MP0008775_abnormal_heart_ventricle | 1.07288711 |
| 75 | MP0004808_abnormal_hematopoietic_stem | 1.07084778 |
| 76 | MP0000371_diluted_coat_color | 1.06387665 |
| 77 | MP0001730_embryonic_growth_arrest | 1.06131625 |
| 78 | MP0000747_muscle_weakness | 1.04163962 |
| 79 | MP0001216_abnormal_epidermal_layer | 1.03267982 |
| 80 | MP0000598_abnormal_liver_morphology | 1.02893369 |
| 81 | MP0000013_abnormal_adipose_tissue | 1.00130915 |
| 82 | MP0003984_embryonic_growth_retardation | 0.99619430 |
| 83 | MP0003690_abnormal_glial_cell | 0.98440066 |
| 84 | MP0004036_abnormal_muscle_relaxation | 0.98365751 |
| 85 | MP0008260_abnormal_autophagy | 0.97854627 |
| 86 | MP0008438_abnormal_cutaneous_collagen | 0.97732497 |
| 87 | MP0004087_abnormal_muscle_fiber | 0.97429842 |
| 88 | MP0005448_abnormal_energy_balance | 0.96845375 |
| 89 | MP0010368_abnormal_lymphatic_system | 0.96648215 |
| 90 | MP0003303_peritoneal_inflammation | 0.96333524 |
| 91 | MP0010307_abnormal_tumor_latency | 0.96293733 |
| 92 | MP0005464_abnormal_platelet_physiology | 0.96045136 |
| 93 | MP0002088_abnormal_embryonic_growth/wei | 0.95684865 |
| 94 | MP0005501_abnormal_skin_physiology | 0.95286900 |
| 95 | MP0001849_ear_inflammation | 0.95128230 |
| 96 | MP0002970_abnormal_white_adipose | 0.94260884 |
| 97 | MP0002098_abnormal_vibrissa_morphology | 0.94025789 |
| 98 | MP0000383_abnormal_hair_follicle | 0.93497053 |
| 99 | MP0000377_abnormal_hair_follicle | 0.93140390 |
| 100 | MP0004043_abnormal_pH_regulation | 0.92991645 |
| 101 | MP0005535_abnormal_body_temperature | 0.90455631 |
| 102 | MP0006138_congestive_heart_failure | 0.90131880 |
| 103 | MP0005310_abnormal_salivary_gland | 0.89830460 |
| 104 | MP0001672_abnormal_embryogenesis/_devel | 0.85946191 |
| 105 | MP0005380_embryogenesis_phenotype | 0.85946191 |
| 106 | MP0000733_abnormal_muscle_development | 0.85406221 |
| 107 | MP0000751_myopathy | 0.84446801 |
| 108 | MP0004947_skin_inflammation | 0.84217418 |
| 109 | MP0002138_abnormal_hepatobiliary_system | 0.81705806 |
| 110 | MP0001851_eye_inflammation | 0.81578684 |
| 111 | MP0003828_pulmonary_edema | 0.79854765 |
| 112 | MP0003453_abnormal_keratinocyte_physiol | 0.79846298 |
| 113 | MP0002089_abnormal_postnatal_growth/wei | 0.79486267 |
| 114 | MP0000767_abnormal_smooth_muscle | 0.78289391 |
| 115 | MP0002998_abnormal_bone_remodeling | 0.77028164 |
| 116 | MP0010630_abnormal_cardiac_muscle | 0.76280485 |
| 117 | MP0004019_abnormal_vitamin_homeostasis | 0.76228756 |
| 118 | MP0005384_cellular_phenotype | 0.75999676 |
| 119 | MP0009115_abnormal_fat_cell | 0.75669660 |
| 120 | MP0002168_other_aberrant_phenotype | 0.74953408 |
| 121 | MP0003091_abnormal_cell_migration | 0.74780121 |
| 122 | MP0005023_abnormal_wound_healing | 0.74408873 |
| 123 | MP0004859_abnormal_synaptic_plasticity | 0.74091337 |
| 124 | MP0004782_abnormal_surfactant_physiolog | 0.73676642 |
| 125 | MP0001756_abnormal_urination | 0.72481136 |
| 126 | MP0003183_abnormal_peptide_metabolism | 0.71732338 |
| 127 | MP0001661_extended_life_span | 0.71608684 |
| 128 | MP0005330_cardiomyopathy | 0.71424100 |
| 129 | MP0001348_abnormal_lacrimal_gland | 0.70583890 |
| 130 | MP0006054_spinal_hemorrhage | 0.68871410 |
| 131 | MP0003221_abnormal_cardiomyocyte_apopto | 0.68479387 |
| 132 | MP0009672_abnormal_birth_weight | 0.67384128 |
| 133 | MP0000350_abnormal_cell_proliferation | 0.66017628 |
| 134 | MP0004147_increased_porphyrin_level | 0.65084267 |
| 135 | MP0003763_abnormal_thymus_physiology | 0.64780552 |
| 136 | MP0000462_abnormal_digestive_system | 0.64762609 |
| 137 | MP0003943_abnormal_hepatobiliary_system | 0.64551736 |
| 138 | MP0000858_altered_metastatic_potential | 0.64496147 |
| 139 | MP0001944_abnormal_pancreas_morphology | 0.64228142 |
| 140 | MP0003646_muscle_fatigue | 0.63708239 |
| 141 | MP0003633_abnormal_nervous_system | 0.63604360 |
| 142 | MP0009642_abnormal_blood_homeostasis | 0.63483671 |
| 143 | MP0005167_abnormal_blood-brain_barrier | 0.62226518 |
| 144 | MP0002090_abnormal_vision | 0.62132414 |
| 145 | MP0005275_abnormal_skin_tensile | 0.62047822 |
| 146 | MP0004858_abnormal_nervous_system | 0.61862594 |
| 147 | MP0002693_abnormal_pancreas_physiology | 0.61396121 |
| 148 | MP0003283_abnormal_digestive_organ | 0.61170150 |
| 149 | MP0005636_abnormal_mineral_homeostasis | 0.59586754 |
| 150 | MP0002896_abnormal_bone_mineralization | 0.59197468 |
| 151 | MP0009763_increased_sensitivity_to | 0.58212725 |
| 152 | MP0001765_abnormal_ion_homeostasis | 0.58174437 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 4.09078650 |
| 2 | Xanthomatosis (HP:0000991) | 3.93774831 |
| 3 | Poikilocytosis (HP:0004447) | 3.79146250 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 3.68999427 |
| 5 | Bilateral sensorineural hearing impairment (HP:0008619) | 3.68009419 |
| 6 | Flat acetabular roof (HP:0003180) | 3.62509572 |
| 7 | Acanthocytosis (HP:0001927) | 3.37339777 |
| 8 | Status epilepticus (HP:0002133) | 3.26280204 |
| 9 | Global brain atrophy (HP:0002283) | 3.19400682 |
| 10 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.14044854 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 2.95777739 |
| 12 | Hypoglycemic coma (HP:0001325) | 2.92035814 |
| 13 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.87749270 |
| 14 | Reticulocytosis (HP:0001923) | 2.87206991 |
| 15 | Ketosis (HP:0001946) | 2.86460067 |
| 16 | Hypoalphalipoproteinemia (HP:0003233) | 2.81833961 |
| 17 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.79072076 |
| 18 | Osteolytic defects of the hand bones (HP:0009699) | 2.79072076 |
| 19 | Asymmetry of the thorax (HP:0001555) | 2.76870694 |
| 20 | Ankyloglossia (HP:0010296) | 2.70003457 |
| 21 | Epidermoid cyst (HP:0200040) | 2.67428820 |
| 22 | Resting tremor (HP:0002322) | 2.66804858 |
| 23 | Complement deficiency (HP:0004431) | 2.64885769 |
| 24 | Myocardial infarction (HP:0001658) | 2.62714913 |
| 25 | Papillary thyroid carcinoma (HP:0002895) | 2.61705365 |
| 26 | Abnormality of the common coagulation pathway (HP:0010990) | 2.61178566 |
| 27 | Cholelithiasis (HP:0001081) | 2.58796838 |
| 28 | Arterial tortuosity (HP:0005116) | 2.58723852 |
| 29 | Ketoacidosis (HP:0001993) | 2.56624109 |
| 30 | Hyporeflexia of lower limbs (HP:0002600) | 2.55119003 |
| 31 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.54970862 |
| 32 | Abnormal gallbladder morphology (HP:0012437) | 2.53987218 |
| 33 | Hyperbilirubinemia (HP:0002904) | 2.53470305 |
| 34 | Skin nodule (HP:0200036) | 2.51566824 |
| 35 | Hyperammonemia (HP:0001987) | 2.50366965 |
| 36 | Hypolipoproteinemia (HP:0010981) | 2.49601992 |
| 37 | Hypobetalipoproteinemia (HP:0003563) | 2.44496821 |
| 38 | Macroorchidism (HP:0000053) | 2.44403002 |
| 39 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.40056266 |
| 40 | Subacute progressive viral hepatitis (HP:0006572) | 2.39655347 |
| 41 | Vertebral compression fractures (HP:0002953) | 2.35420907 |
| 42 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.34061792 |
| 43 | Protrusio acetabuli (HP:0003179) | 2.32427113 |
| 44 | Abnormality of the intrinsic pathway (HP:0010989) | 2.32187282 |
| 45 | Polycythemia (HP:0001901) | 2.32013485 |
| 46 | Cerebral inclusion bodies (HP:0100314) | 2.31995711 |
| 47 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 2.30465301 |
| 48 | Increased CSF protein (HP:0002922) | 2.29876908 |
| 49 | Sparse lateral eyebrow (HP:0005338) | 2.28517548 |
| 50 | Abnormality of oral frenula (HP:0000190) | 2.24240508 |
| 51 | Upper limb amyotrophy (HP:0009129) | 2.23747122 |
| 52 | Distal upper limb amyotrophy (HP:0007149) | 2.23747122 |
| 53 | Abnormal foot bone ossification (HP:0010675) | 2.20835337 |
| 54 | Cerebral aneurysm (HP:0004944) | 2.20348893 |
| 55 | Dysmetric saccades (HP:0000641) | 2.19904371 |
| 56 | Hypercholesterolemia (HP:0003124) | 2.19666872 |
| 57 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.19601792 |
| 58 | Vascular tortuosity (HP:0004948) | 2.17776360 |
| 59 | Coarse hair (HP:0002208) | 2.17359301 |
| 60 | Hyperglycinuria (HP:0003108) | 2.17117085 |
| 61 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.16498759 |
| 62 | Broad face (HP:0000283) | 2.15696263 |
| 63 | Abnormality of carpal bone ossification (HP:0006257) | 2.13088138 |
| 64 | Myoglobinuria (HP:0002913) | 2.12678971 |
| 65 | Hyperglycemia (HP:0003074) | 2.12446011 |
| 66 | Increased cerebral lipofuscin (HP:0011813) | 2.12245740 |
| 67 | Sensorimotor neuropathy (HP:0007141) | 2.12116882 |
| 68 | Deep philtrum (HP:0002002) | 2.11127494 |
| 69 | Advanced eruption of teeth (HP:0006288) | 2.09149158 |
| 70 | Cardiovascular calcification (HP:0011915) | 2.08514481 |
| 71 | Abnormality of the fingertips (HP:0001211) | 2.07970284 |
| 72 | Hand muscle atrophy (HP:0009130) | 2.07235313 |
| 73 | Vascular calcification (HP:0004934) | 2.06287461 |
| 74 | Back pain (HP:0003418) | 2.06262759 |
| 75 | Prolonged partial thromboplastin time (HP:0003645) | 2.05485184 |
| 76 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.03363912 |
| 77 | Abnormality of glycine metabolism (HP:0010895) | 2.03363912 |
| 78 | Abnormality of complement system (HP:0005339) | 2.02767093 |
| 79 | Mitral stenosis (HP:0001718) | 2.01530663 |
| 80 | Abnormality of the Achilles tendon (HP:0005109) | 2.01506478 |
| 81 | Hepatocellular carcinoma (HP:0001402) | 2.01187674 |
| 82 | Menorrhagia (HP:0000132) | 1.99952055 |
| 83 | Focal seizures (HP:0007359) | 1.98204584 |
| 84 | Aneurysm (HP:0002617) | 1.97565072 |
| 85 | Gout (HP:0001997) | 1.97170955 |
| 86 | Spinal cord lesions (HP:0100561) | 1.96910565 |
| 87 | Syringomyelia (HP:0003396) | 1.96910565 |
| 88 | Short nail (HP:0001799) | 1.95921075 |
| 89 | Abnormal ossification of hand bones (HP:0005921) | 1.95784692 |
| 90 | Distal lower limb amyotrophy (HP:0008944) | 1.94937743 |
| 91 | Hypoglycemic seizures (HP:0002173) | 1.94859703 |
| 92 | Hemorrhage of the eye (HP:0011885) | 1.94355598 |
| 93 | Relative macrocephaly (HP:0004482) | 1.94134788 |
| 94 | Hemiparesis (HP:0001269) | 1.94082076 |
| 95 | Abnormal tarsal ossification (HP:0008369) | 1.93863131 |
| 96 | Increased mean platelet volume (HP:0011877) | 1.93646093 |
| 97 | Abnormality of proline metabolism (HP:0010907) | 1.92531070 |
| 98 | Hydroxyprolinuria (HP:0003080) | 1.92531070 |
| 99 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.92332493 |
| 100 | Difficulty running (HP:0009046) | 1.92214370 |
| 101 | Right ventricular cardiomyopathy (HP:0011663) | 1.91038230 |
| 102 | Turricephaly (HP:0000262) | 1.90921131 |
| 103 | Neurofibrillary tangles (HP:0002185) | 1.90880350 |
| 104 | Conjugated hyperbilirubinemia (HP:0002908) | 1.90529256 |
| 105 | Hyperglycinemia (HP:0002154) | 1.90484336 |
| 106 | Hypercortisolism (HP:0001578) | 1.88670503 |
| 107 | Abnormality of purine metabolism (HP:0004352) | 1.88646835 |
| 108 | Severe Myopia (HP:0011003) | 1.85957099 |
| 109 | Supranuclear gaze palsy (HP:0000605) | 1.85644387 |
| 110 | Thin bony cortex (HP:0002753) | 1.85425408 |
| 111 | Hyperacusis (HP:0010780) | 1.85372842 |
| 112 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.84853606 |
| 113 | Postural instability (HP:0002172) | 1.83109338 |
| 114 | Abnormal cartilage morphology (HP:0002763) | 1.83001559 |
| 115 | Esophageal varix (HP:0002040) | 1.82984927 |
| 116 | Abnormality of the gallbladder (HP:0005264) | 1.82842065 |
| 117 | Asymmetric septal hypertrophy (HP:0001670) | 1.82425585 |
| 118 | Abnormality of the acetabulum (HP:0003170) | 1.82033003 |
| 119 | Dislocated radial head (HP:0003083) | 1.81690601 |
| 120 | Curly hair (HP:0002212) | 1.80703645 |
| 121 | Bundle branch block (HP:0011710) | 1.80061681 |
| 122 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.78461091 |
| 123 | Mitral valve prolapse (HP:0001634) | 1.77081034 |
| 124 | Long toe (HP:0010511) | 1.76833802 |
| 125 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.76357828 |
| 126 | Abnormality of vision evoked potentials (HP:0000649) | 1.76145496 |
| 127 | Abnormality of the lower motor neuron (HP:0002366) | 1.76095537 |
| 128 | Aortic aneurysm (HP:0004942) | 1.75911019 |
| 129 | Increased connective tissue (HP:0009025) | 1.75335263 |
| 130 | Testicular atrophy (HP:0000029) | 1.74607344 |
| 131 | Termporal pattern (HP:0011008) | 1.73820029 |
| 132 | Insidious onset (HP:0003587) | 1.73820029 |
| 133 | Abnormal gallbladder physiology (HP:0012438) | 1.73780133 |
| 134 | Cholecystitis (HP:0001082) | 1.73780133 |
| 135 | Aortic dissection (HP:0002647) | 1.73683961 |
| 136 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.73476996 |
| 137 | Mucopolysacchariduria (HP:0008155) | 1.73476996 |
| 138 | Premature rupture of membranes (HP:0001788) | 1.73309189 |
| 139 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.72989142 |
| 140 | Fat malabsorption (HP:0002630) | 1.72776518 |
| 141 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.72244701 |
| 142 | Achilles tendon contracture (HP:0001771) | 1.71868823 |
| 143 | Abnormal hand bone ossification (HP:0010660) | 1.71813585 |
| 144 | Lymphangioma (HP:0100764) | 1.71547283 |
| 145 | Abnormality of the nasal septum (HP:0000419) | 1.71245319 |
| 146 | Colitis (HP:0002583) | 1.68915103 |
| 147 | Narrow palate (HP:0000189) | 1.65745791 |
| 148 | Missing ribs (HP:0000921) | 1.65660318 |
| 149 | Micronodular cirrhosis (HP:0001413) | 1.65362686 |
| 150 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.64339428 |
| 151 | Wormian bones (HP:0002645) | 1.63365625 |
| 152 | Abnormality of the radial head (HP:0003995) | 1.61863641 |
| 153 | Menstrual irregularities (HP:0000858) | 1.61353134 |
| 154 | * Heterotopia (HP:0002282) | 1.61190180 |
| 155 | Abnormality of the gastric mucosa (HP:0004295) | 1.61015177 |
| 156 | Germ cell neoplasia (HP:0100728) | 1.60921562 |
| 157 | Testicular neoplasm (HP:0010788) | 1.59898064 |
| 158 | Gingival bleeding (HP:0000225) | 1.59412014 |
| 159 | Bone pain (HP:0002653) | 1.59392621 |
| 160 | Neonatal death (HP:0003811) | 1.57316115 |
| 161 | Leiomyosarcoma (HP:0100243) | 1.56637192 |
| 162 | Uterine leiomyosarcoma (HP:0002891) | 1.56637192 |
| 163 | Cervical subluxation (HP:0003308) | 1.55432306 |
| 164 | Cubitus valgus (HP:0002967) | 1.55169301 |
| 165 | Hypopigmentation of the fundus (HP:0007894) | 1.54889979 |
| 166 | Thyroid carcinoma (HP:0002890) | 1.54218953 |
| 167 | Natal tooth (HP:0000695) | 1.53289218 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.60873082 |
| 2 | TAOK3 | 3.09294697 |
| 3 | MST1R | 3.07939549 |
| 4 | PKN2 | 2.43848368 |
| 5 | ERN1 | 2.40186169 |
| 6 | SIK1 | 2.35111218 |
| 7 | AKT3 | 2.18209336 |
| 8 | SCYL2 | 2.05942487 |
| 9 | PRPF4B | 2.04936296 |
| 10 | EPHA2 | 1.99412712 |
| 11 | RIPK1 | 1.93841886 |
| 12 | CAMK1D | 1.85221139 |
| 13 | CAMK1G | 1.80604974 |
| 14 | EEF2K | 1.75703800 |
| 15 | MAP3K2 | 1.74921394 |
| 16 | CDK12 | 1.73073009 |
| 17 | PTK6 | 1.71941433 |
| 18 | TTN | 1.66031664 |
| 19 | PDGFRA | 1.64912482 |
| 20 | IRAK3 | 1.60955144 |
| 21 | MAP3K10 | 1.58950773 |
| 22 | PTK2 | 1.57706926 |
| 23 | LATS1 | 1.55481827 |
| 24 | TRPM7 | 1.53047599 |
| 25 | FGFR4 | 1.51256886 |
| 26 | KSR2 | 1.50288288 |
| 27 | SMG1 | 1.43417968 |
| 28 | BCKDK | 1.42196468 |
| 29 | BRD4 | 1.40862876 |
| 30 | ICK | 1.39347737 |
| 31 | RET | 1.39294030 |
| 32 | MAP3K9 | 1.31898182 |
| 33 | TAOK1 | 1.30116154 |
| 34 | EPHB1 | 1.29945156 |
| 35 | NEK6 | 1.28432811 |
| 36 | PDK3 | 1.27558709 |
| 37 | PDK4 | 1.27558709 |
| 38 | NTRK1 | 1.27401438 |
| 39 | MAP3K7 | 1.27388914 |
| 40 | DYRK1B | 1.22659313 |
| 41 | SGK3 | 1.21869032 |
| 42 | FRK | 1.18155888 |
| 43 | PRKD3 | 1.17489894 |
| 44 | STK38 | 1.15600726 |
| 45 | BMX | 1.15407089 |
| 46 | JAK2 | 1.14226088 |
| 47 | MELK | 1.12963991 |
| 48 | STK39 | 1.11918431 |
| 49 | MAP3K14 | 1.10793391 |
| 50 | JAK1 | 1.10324735 |
| 51 | PDGFRB | 1.08654736 |
| 52 | ALK | 1.06594703 |
| 53 | INSRR | 1.06447316 |
| 54 | MTOR | 1.05986318 |
| 55 | CDK6 | 1.04303290 |
| 56 | PDPK1 | 1.00715632 |
| 57 | RPS6KB2 | 1.00084192 |
| 58 | RIPK4 | 0.99877127 |
| 59 | WNK1 | 0.99768598 |
| 60 | LMTK2 | 0.98735473 |
| 61 | EIF2AK3 | 0.96894128 |
| 62 | PRKCH | 0.95053964 |
| 63 | ERBB4 | 0.94701759 |
| 64 | PRKAA1 | 0.94461875 |
| 65 | PDK1 | 0.94381228 |
| 66 | CAMKK1 | 0.93055987 |
| 67 | FGFR3 | 0.92517424 |
| 68 | STK24 | 0.90824655 |
| 69 | PBK | 0.89366201 |
| 70 | EIF2AK1 | 0.88750676 |
| 71 | FLT3 | 0.86672164 |
| 72 | MAP3K3 | 0.85622608 |
| 73 | PRKAA2 | 0.84178685 |
| 74 | LRRK2 | 0.82775609 |
| 75 | FGFR2 | 0.81147468 |
| 76 | MAP2K4 | 0.80225944 |
| 77 | DAPK2 | 0.79975169 |
| 78 | MAP3K1 | 0.79666046 |
| 79 | PIK3CA | 0.78447645 |
| 80 | MET | 0.76290923 |
| 81 | DMPK | 0.75288574 |
| 82 | STK3 | 0.73817789 |
| 83 | RPS6KA2 | 0.71808874 |
| 84 | SGK2 | 0.69963464 |
| 85 | PAK6 | 0.68673099 |
| 86 | PAK4 | 0.68272438 |
| 87 | BMPR2 | 0.66380640 |
| 88 | DDR2 | 0.66286270 |
| 89 | CDC42BPA | 0.65844147 |
| 90 | PAK3 | 0.65232980 |
| 91 | RPS6KB1 | 0.64915252 |
| 92 | PRKD1 | 0.64905856 |
| 93 | STK38L | 0.62681336 |
| 94 | LATS2 | 0.62270975 |
| 95 | HIPK2 | 0.62113609 |
| 96 | YES1 | 0.61959722 |
| 97 | TYRO3 | 0.61651833 |
| 98 | STK10 | 0.61423359 |
| 99 | PAK2 | 0.60417129 |
| 100 | MAP2K3 | 0.59229456 |
| 101 | MAP3K6 | 0.57461340 |
| 102 | CDK7 | 0.57393082 |
| 103 | STK11 | 0.56397429 |
| 104 | MARK2 | 0.54965394 |
| 105 | TYK2 | 0.54282832 |
| 106 | TGFBR2 | 0.54273579 |
| 107 | TBK1 | 0.54205019 |
| 108 | MAP2K1 | 0.54172441 |
| 109 | GRK6 | 0.52200538 |
| 110 | FGFR1 | 0.51449004 |
| 111 | CDK4 | 0.50698578 |
| 112 | STK4 | 0.50589366 |
| 113 | SGK223 | 0.48986312 |
| 114 | SGK494 | 0.48986312 |
| 115 | TSSK6 | 0.48910688 |
| 116 | MAP3K4 | 0.48628325 |
| 117 | WNK4 | 0.48554002 |
| 118 | FER | 0.48246149 |
| 119 | EPHA3 | 0.46880177 |
| 120 | NEK1 | 0.46488970 |
| 121 | NEK9 | 0.46002298 |
| 122 | PDK2 | 0.45881853 |
| 123 | SGK1 | 0.45165848 |
| 124 | EGFR | 0.44605138 |
| 125 | MAP3K13 | 0.43649296 |
| 126 | MAPK11 | 0.43623926 |
| 127 | MAPK10 | 0.43313642 |
| 128 | PRKD2 | 0.42772897 |
| 129 | PIK3CG | 0.42758063 |
| 130 | PRKACG | 0.42746302 |
| 131 | PTK2B | 0.39532155 |
| 132 | PRKCZ | 0.38807844 |
| 133 | KSR1 | 0.38758525 |
| 134 | HCK | 0.38697248 |
| 135 | * RPS6KA3 | 0.38648023 |
| 136 | CHUK | 0.36292127 |
| 137 | ZAP70 | 0.36051837 |
| 138 | MAP3K8 | 0.34205127 |
| 139 | NLK | 0.31919520 |
| 140 | ERBB2 | 0.30891695 |
| 141 | CHEK1 | 0.29030922 |
| 142 | AKT2 | 0.28919361 |
| 143 | RAF1 | 0.27828448 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.93282600 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.23667829 |
| 3 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.52726035 |
| 4 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.51443298 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.29880963 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.04015724 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 1.94151789 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.89013012 |
| 9 | Thyroid cancer_Homo sapiens_hsa05216 | 1.87730945 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.85032415 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.84715672 |
| 12 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.83811776 |
| 13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.78874081 |
| 14 | ABC transporters_Homo sapiens_hsa02010 | 1.78049219 |
| 15 | Bile secretion_Homo sapiens_hsa04976 | 1.75637797 |
| 16 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.74682696 |
| 17 | Adherens junction_Homo sapiens_hsa04520 | 1.72882996 |
| 18 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.66648470 |
| 19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.66550282 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.54559453 |
| 21 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.53014656 |
| 22 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.52548971 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.51838353 |
| 24 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.50126713 |
| 25 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.47201691 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.43090021 |
| 27 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.39991562 |
| 28 | Lysine degradation_Homo sapiens_hsa00310 | 1.38736927 |
| 29 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.37664079 |
| 30 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.32804907 |
| 31 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.30933955 |
| 32 | Prostate cancer_Homo sapiens_hsa05215 | 1.30018788 |
| 33 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.28158951 |
| 34 | Bladder cancer_Homo sapiens_hsa05219 | 1.24642397 |
| 35 | Insulin resistance_Homo sapiens_hsa04931 | 1.23570164 |
| 36 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.22223288 |
| 37 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.20800719 |
| 38 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.18091777 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.17936200 |
| 40 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.17415135 |
| 41 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.17295610 |
| 42 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.13412758 |
| 43 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.12405719 |
| 44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.10609727 |
| 45 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.09409810 |
| 46 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.07886277 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.06652149 |
| 48 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.05820228 |
| 49 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.05061881 |
| 50 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.02210019 |
| 51 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.00504055 |
| 52 | Peroxisome_Homo sapiens_hsa04146 | 0.99194124 |
| 53 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.96362757 |
| 54 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.96152123 |
| 55 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.95182659 |
| 56 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.93967717 |
| 57 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.93029110 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.91625898 |
| 59 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.90541616 |
| 60 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.89676964 |
| 61 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.87867646 |
| 62 | Platelet activation_Homo sapiens_hsa04611 | 0.86942893 |
| 63 | Long-term potentiation_Homo sapiens_hsa04720 | 0.86512130 |
| 64 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.86474686 |
| 65 | Hepatitis C_Homo sapiens_hsa05160 | 0.86373526 |
| 66 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.86261700 |
| 67 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.82831166 |
| 68 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.82556876 |
| 69 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.81664345 |
| 70 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.81550743 |
| 71 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.77928218 |
| 72 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.75871532 |
| 73 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.75437964 |
| 74 | Colorectal cancer_Homo sapiens_hsa05210 | 0.75375627 |
| 75 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.75190313 |
| 76 | Hepatitis B_Homo sapiens_hsa05161 | 0.75147270 |
| 77 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.75067196 |
| 78 | Histidine metabolism_Homo sapiens_hsa00340 | 0.74026355 |
| 79 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.73801522 |
| 80 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.73313319 |
| 81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.71733478 |
| 82 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.71729769 |
| 83 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.69642491 |
| 84 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69383216 |
| 85 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.68350562 |
| 86 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.66862513 |
| 87 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.66788310 |
| 88 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.66746910 |
| 89 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.65692926 |
| 90 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.65339682 |
| 91 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.64770652 |
| 92 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63837491 |
| 93 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.61260460 |
| 94 | Lysosome_Homo sapiens_hsa04142 | 0.59961648 |
| 95 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.59584634 |
| 96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.59030525 |
| 97 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.58236595 |
| 98 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.57618709 |
| 99 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.57350376 |
| 100 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.57159409 |
| 101 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.57040214 |
| 102 | Circadian rhythm_Homo sapiens_hsa04710 | 0.56428513 |
| 103 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.55641846 |
| 104 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.55184891 |
| 105 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.53411924 |
| 106 | Tight junction_Homo sapiens_hsa04530 | 0.52755866 |
| 107 | Influenza A_Homo sapiens_hsa05164 | 0.52511887 |
| 108 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.50286851 |
| 109 | Insulin secretion_Homo sapiens_hsa04911 | 0.48657299 |
| 110 | Salivary secretion_Homo sapiens_hsa04970 | 0.48314164 |
| 111 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.48224120 |
| 112 | * Endocytosis_Homo sapiens_hsa04144 | 0.48178854 |
| 113 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.47931211 |
| 114 | Apoptosis_Homo sapiens_hsa04210 | 0.47315355 |
| 115 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.46951592 |
| 116 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.46174501 |
| 117 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45847957 |
| 118 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.44479824 |
| 119 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.44186809 |
| 120 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.43138499 |
| 121 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.42244571 |
| 122 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.42099159 |
| 123 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.41246187 |
| 124 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.40768032 |
| 125 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.40701552 |
| 126 | Amoebiasis_Homo sapiens_hsa05146 | 0.40511125 |
| 127 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.39383241 |
| 128 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.38851827 |
| 129 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.38439720 |
| 130 | Glioma_Homo sapiens_hsa05214 | 0.38175396 |
| 131 | Prion diseases_Homo sapiens_hsa05020 | 0.38095482 |
| 132 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.35165134 |
| 133 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.34956251 |
| 134 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.33607843 |
| 135 | Focal adhesion_Homo sapiens_hsa04510 | 0.33601073 |
| 136 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.33476346 |
| 137 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.33394739 |
| 138 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.32768145 |
| 139 | Endometrial cancer_Homo sapiens_hsa05213 | 0.32658063 |
| 140 | Retinol metabolism_Homo sapiens_hsa00830 | 0.30765992 |
| 141 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.30513694 |
| 142 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.30385753 |
| 143 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.30338934 |
| 144 | Galactose metabolism_Homo sapiens_hsa00052 | 0.29369927 |
| 145 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.28955950 |

